Matches in Wikidata for { <http://www.wikidata.org/entity/Q103723844> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q103723844 description "2020 ވަނަ އަހަރުގެ ނޮވެމްބަރުމަހުގެ 30ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q103723844 description "artículu científicu espublizáu en payares de 2020" @default.
- Q103723844 description "scientific article published on 30 November 2020" @default.
- Q103723844 description "wetenschappelijk artikel" @default.
- Q103723844 description "наукова стаття, опублікована 30 листопада 2020" @default.
- Q103723844 name "Clinical Outcomes of 130 Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Palbociclib plus Endocrine Therapy and Subsequent Therapy: A Real-World Single-Center Retros" @default.
- Q103723844 name "Clinical Outcomes of 130 Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Palbociclib plus Endocrine Therapy and Subsequent Therapy: A Real-World Single-Center Retros" @default.
- Q103723844 name "Clinical Outcomes of 130 Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Palbociclib plus Endocrine Therapy and Subsequent Therapy: A Real-World Single-Center Retros" @default.
- Q103723844 type Item @default.
- Q103723844 label "Clinical Outcomes of 130 Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Palbociclib plus Endocrine Therapy and Subsequent Therapy: A Real-World Single-Center Retros" @default.
- Q103723844 label "Clinical Outcomes of 130 Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Palbociclib plus Endocrine Therapy and Subsequent Therapy: A Real-World Single-Center Retros" @default.
- Q103723844 label "Clinical Outcomes of 130 Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Palbociclib plus Endocrine Therapy and Subsequent Therapy: A Real-World Single-Center Retros" @default.
- Q103723844 prefLabel "Clinical Outcomes of 130 Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Palbociclib plus Endocrine Therapy and Subsequent Therapy: A Real-World Single-Center Retros" @default.
- Q103723844 prefLabel "Clinical Outcomes of 130 Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Palbociclib plus Endocrine Therapy and Subsequent Therapy: A Real-World Single-Center Retros" @default.
- Q103723844 prefLabel "Clinical Outcomes of 130 Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Palbociclib plus Endocrine Therapy and Subsequent Therapy: A Real-World Single-Center Retros" @default.
- Q103723844 P1433 Q103723844-CA9698F0-F7FB-445C-B37D-E47FFA24F1A1 @default.
- Q103723844 P1476 Q103723844-FC316CFA-BF43-4743-9C70-4751D3DA23FF @default.
- Q103723844 P2093 Q103723844-0A6AACFE-AAE4-462B-A751-D230C3A18E94 @default.
- Q103723844 P2093 Q103723844-1BAB31E3-F8C8-47AD-9085-0C2408A789A0 @default.
- Q103723844 P2093 Q103723844-23233328-6516-4CD9-8EA0-1047B8F746D7 @default.
- Q103723844 P2093 Q103723844-65DEE59A-1639-49AC-8DE2-B47EAFD3B5FD @default.
- Q103723844 P2093 Q103723844-6D4B67D3-17DD-4E06-A8EA-1B0DECDCE2A1 @default.
- Q103723844 P2093 Q103723844-B4C34990-5AC2-400B-81F1-AC4569D697A9 @default.
- Q103723844 P2093 Q103723844-C4213BA5-AAE6-4C51-A5F2-CBDA2368F109 @default.
- Q103723844 P2093 Q103723844-E4CB7FE5-7A7A-4FC4-91EC-8838C405F5A7 @default.
- Q103723844 P304 Q103723844-8F6E73D6-59C6-4117-A781-00C9C69CE599 @default.
- Q103723844 P31 Q103723844-59C2AEDA-26D2-4320-88B0-5FE1CD87C15E @default.
- Q103723844 P356 Q103723844-FE2F6BC6-BAB9-4E83-B082-A0272686155C @default.
- Q103723844 P478 Q103723844-FAD31463-A185-4FD2-AD63-62DDB73E09AB @default.
- Q103723844 P577 Q103723844-4C5701A1-F1ED-4B94-9433-CB458DFB7D88 @default.
- Q103723844 P698 Q103723844-91997CA4-9640-48BF-8805-CDBF2F69F601 @default.
- Q103723844 P921 Q103723844-217698E0-BB2B-41BD-B4D5-B80E04F70146 @default.
- Q103723844 P932 Q103723844-DCC84A31-95E0-44EE-9804-808CFF34BFB7 @default.
- Q103723844 P356 MSM.927187 @default.
- Q103723844 P698 33250509 @default.
- Q103723844 P1433 Q15756323 @default.
- Q103723844 P1476 "Clinical Outcomes of 130 Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Palbociclib plus Endocrine Therapy and Subsequent Therapy: A Real-World Single-Center Retrospective Study in China" @default.
- Q103723844 P2093 "Biyun Wang" @default.
- Q103723844 P2093 "Chang Liu" @default.
- Q103723844 P2093 "Jian Zhang" @default.
- Q103723844 P2093 "Jun Cao" @default.
- Q103723844 P2093 "Leiping Wang" @default.
- Q103723844 P2093 "Ting Li" @default.
- Q103723844 P2093 "Xichun Hu" @default.
- Q103723844 P2093 "Zhonghua Tao" @default.
- Q103723844 P304 "e927187" @default.
- Q103723844 P31 Q13442814 @default.
- Q103723844 P356 "10.12659/MSM.927187" @default.
- Q103723844 P478 "26" @default.
- Q103723844 P577 "2020-11-30T00:00:00Z" @default.
- Q103723844 P698 "33250509" @default.
- Q103723844 P921 Q12859063 @default.
- Q103723844 P932 "7716621" @default.